Noticias de BIAF_US

Noticias del mercado

Últimas noticias sobre BIAF_US — 78 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: BIAF_US ✕ 78 resultados
23/03/2026 BIAF_US — Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session - Firefly Neuroscience (NASDAQ:AIFF), Allogene
23/03/2026 BIAF_US — Quiver Quantitative
bioAffinity Technologies shares soar as investors react to upbeat CyPath Lung growth update and 2026 outlook
21/03/2026 BIAF_US — Stock Titan ES ← EN
Si invirtió $1000 en bioAffinity Tech (BIAF)
19/03/2026 BIAF_US — Benzinga
What's Going On With bioAffinity Stock Thursday?
17/03/2026 BIAF_US — Yahoo Finance
New Case Study: bioAffinity Technologies’ CyPath® Lung Provides Actionable Results and Helps Patient Avoid Costly, Invasive Procedures
17/03/2026 BIAF_US — Benzinga
Why Is bioAffinity Technologies Stock Surging Tuesday?
17/03/2026 BIAF_US — timothysykes.com
CyPath Lung Diagnostic Tool Spurs bioAffinity Technologies’ Growth
17/03/2026 BIAF_US — TipRanks
bioAffinity Showcases CyPath Lung Case Study in Diagnostics
17/03/2026 BIAF_US — Minichart
bioAffinity Technologies 2024 Annual Report: Business Overview, Clinical Trial Updates, and Key Risks for Diagnostic and Therapeutic Product Development
16/03/2026 BIAF_US — TradingView
bioAffinity Technologies 10-K: Revenue $6.16M, EPS $(8.66)
16/03/2026 BIAF_US — Benzinga
bioAffinity Technologies Stock Cools Off After Strong Friday Rally - Here's Why
16/03/2026 BIAF_US — Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
15/03/2026 BIAF_US — MarketBeat
Promising Biotech Stocks To Add to Your Watchlist - March 15th
14/03/2026 BIAF_US — timothysykes.com
BioAffinity Technologies Projects Strong Growth Amid Market Fluctuations
13/03/2026 BIAF_US — Benzinga
bioAffinity Technologies Stock Soars 120% On CyPath Lung Sales Growth
13/03/2026 BIAF_US — Business Wire
bioAffinity Technologies Announces Record 2025 Revenue and Unit Sales for Flagship Lung Cancer Diagnostic CyPath® Lung
13/03/2026 BIAF_US — Stock Titan
CyPath Lung growth accelerates while bioAffinity (NASDAQ: BIAF) posts larger 2025 loss
13/03/2026 BIAF_US — Investing.com
bioAffinity Technologies reports 2025 financial results
13/03/2026 BIAF_US — timothysykes.com
BioAffinity Technologies Shakes Up Diagnostics Field with Innovative Clinical Initiatives
13/03/2026 BIAF_US — TradingView
BIAF: CyPath® Lung test sales surged 99% in 2025, driving record revenue and future growth momentum

Página 3 de 4

keyboard_arrow_up